Coronavirus – Vaccines: Safe and Effective in Most Lung Cancer Patients

Get real time updates directly on you device, subscribe now.

The coronavirus mRNA vaccines is safe and Efficiently in patients with cancer lungs, most of whom gain immune protection after two doses, according to a new French scientific study. study.

Still, it was found that when a third booster dose was given to 11% of patients who had low levels of antibodies after the two doses, then almost nine out of ten (88%) also acquired adequate antibody protection.

Although the Covid-19 vaccines have long been shown to be generally safe and effective in the general population, little was known about whether patients with lung / chest cancer develop an adequate immune response, as they were initially excluded from most vaccine trials. Also previous studies had shown that these patients had a mortality of about 30% of Covid-19, significantly larger than the general population.

Researchers at Bichat-Claude Bernard University Hospital in Paris, published in the Journal of Thoracic Oncology, studied 306 lung cancer patients with a mean age of 67 years. Of those, according to the Athenian-Macedonian News Agency, 283 had received two doses of the Pfizer / BioNTech vaccine 28 days apart (those with coronavirus antibodies due to a previous Covid-19 infection had only received one dose).

After six to seven months, only eight patients (2.6%) had Covid-19 with symptoms but a favorable outcome. 34 (11%) had very low levels of antibodies, especially the elderly, those who had undergone chemotherapy in the last trimester and those who had received long-term treatment with corticosteroids. The 30 gave a third dose and eventually only three patients – who had blood cancers that are known to often respond poorly to vaccines – continued to show very low levels of antibodies.

No cases of anaphylaxis were reported. The researchers, however, pointed out the need for their findings to be confirmed by a larger study.

Get real time updates directly on you device, subscribe now.

Leave A Reply

Your email address will not be published.